More than half of patients who suffer an acute anterior cruciate ligament (ACL) rupture develop arthrogenic muscle inhibition. Also known as AMI, arthrogenic muscle inhibition is a condition that directly impairs knee function and recovery outcomes.
This article is based on a cross-sectional study published by the SANTI Study Group: Incidence of and Risk Factors for Arthrogenic Muscle Inhibition in Acute Anterior Cruciate Ligament Injuries: A Cross-Sectional Study and Analysis of Associated Factors From the SANTI Study Group. For a full understanding of the methodology, statistical analysis, and clinical implications, we strongly encourage you to consult the complete study.
What is arthrogenic muscle inhibition and why does it matter after an ACL injury?
Arthrogenic muscle inhibition (AMI) is a neurological response triggered by injury or surgery to the knee. In simple terms, the nervous system reduces its signals to the quadriceps (the large muscle group at the front of the thigh), causing two measurable problems:
- an inability to fully activate the muscle (known as quadriceps activation failure),
- a deficit in full knee extension, meaning the patient cannot completely straighten the leg.
Although AMI is a well-established concept in orthopaedic rehabilitation, its true prevalence and the factors that predict its occurrence after ACL injury had previously not been rigorously quantified.
The research team for this study assessed 300 consecutive patients with acute ACL ruptures using a standardised physical examination, grading AMI and its reversibility according to the Sonnery-Cottet classification. This classification system proved highly reliable, with near-perfect agreement between observers.
Key finding: 170 out of 300 patients (56.7%) presented with AMI at their first outpatient appointment.
Risk factors, clinical impact, and reversibility
Which patients are most at risk?
The study identified several “red flags” that significantly increase the likelihood of AMI being present. Clinicians should heighten their suspicion when the following factors are observed:
| Risk factor | Clinical significance |
| Joint effusion (swelling inside the knee) | Strong independent predictor |
| High pain scores | Associated with greater inhibition severity |
| Short time between injury and assessment | The sooner after injury, the higher the risk |
| Concomitant ligament injuries | Multiligament damage raises the probability |
| Use of crutches | Reflects limited weight-bearing capacity |
| Using a pillow under the knee at night | Indicates a habitual posture that maintains flexion |
Interestingly, patients with a previous ACL injury (to the same or opposite knee) showed a significantly lower risk of developing AMI (odds ratio: 0.025). The authors suggest this may reflect neurological adaptation from prior rehabilitation. To understand the full statistical picture, the complete study provides detailed multivariate analysis.
What are the consequences for patients?
Patients with AMI scored significantly lower across all functional outcome measures compared to those without, including the Lysholm score, the IKDC score (International Knee Documentation Committee), the Simple Knee Value, and the KOOS (Knee injury and Osteoarthritis Outcome Score).
In practical terms, AMI is not a minor inconvenience: it translates into measurable loss of function from the very early stages of injury.
Key figures show most cases resolve quickly
Of the 170 patients diagnosed with AMI, 135 (79%) showed complete resolution of their inhibition by the end of the same consultation, following simple targeted exercises. Only the remaining 35 patients required a more specific rehabilitation pathway.
This finding is clinically encouraging. Early identification of AMI, guided by the red flags listed above, allows clinicians to intervene immediately with straightforward exercises rather than allowing the inhibition to persist and potentially complicate surgical or conservative management.
The full study details the exact protocols used and the classification criteria, which are well worth reviewing.
Conclusion & Findings
AMI affects the majority of patients with acute ACL injuries and has a measurable impact on early knee function. The good news is that when it is identified early and managed appropriately, it resolves in most patients without complex intervention. Knowing the risk factors, described in detail in the complete SANTI study, is what makes early identification possible.
Professor Cavaignac has published several scientific studies exploring the management and outcomes of ACL injuries; reading them alongside this one gives a far more complete picture of current best practice.
Professor Cavaignac, orthopaedic surgeon specialised in knee surgery and sport traumatology, is available for consultations. If you have questions about a case or would like a specialist’s perspective, do not hesitate to get in touch.